• Inozyme Pharma, Inc.(NasdaqGS: INZY) dropped from S&P TMI Index MarketScreener Wed, 02 Jul 2025 00:22:02 GMT
• BioMarin Completes Acquisition of Inozyme Pharma for $270M Contract Pharma Tue, 01 Jul 2025 14:08:43 GMT
• BioMarin completes acquisition of Inozyme Pharma, triggers delisting from Nasdaq Investing.com Tue, 01 Jul 2025 13:43:52 GMT
• BioMarin Pharmaceutical Closes Acquisition of Inozyme Pharma MarketScreener Tue, 01 Jul 2025 13:29:29 GMT
• BioMarin completes $270 million acquisition of Inozyme Pharma Investing.com Tue, 01 Jul 2025 13:14:40 GMT
• BioMarin Acquires Inozyme for $270M, Gains Late-Stage Enzyme Therapy for Untreated Rare Disease Stock Titan Tue, 01 Jul 2025 12:45:00 GMT
• BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz MSN Mon, 30 Jun 2025 23:42:02 GMT
• Inozyme Pharma Postpones 2025 Annual Meeting of Stockholders Amid BioMarin Acquisition Discussions Nasdaq Fri, 20 Jun 2025 21:10:00 GMT
• Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders GlobeNewswire Fri, 20 Jun 2025 07:00:00 GMT
• Inozyme Pharma Halts Annual Meeting as BioMarin Acquisition Nears Completion Stock Titan Fri, 20 Jun 2025 07:00:00 GMT
• Inozyme Pharma Postpones Annual Meeting Amid BioMarin Acquisition Talks | INZY SEC Filing - Form DEFA14A Stock Titan Fri, 20 Jun 2025 07:00:00 GMT
• The BioMarin-Inozyme Deal: A Strategic Gamble or a Pipeline Lifeline? AInvest Fri, 20 Jun 2025 07:00:00 GMT
• biomarin offers to buy inozyme for $270m to boost enzyme therapy biz MSN Fri, 13 Jun 2025 17:45:18 GMT
• Inozyme Pharma (INZY) Rises 0.25% on BioMarin Acquisition News AInvest Wed, 04 Jun 2025 07:00:00 GMT
• inozyme pharma announces executive bonuses amid merger plans Investing.com Mon, 02 Jun 2025 07:00:00 GMT
• beryl capital management llc acquires significant stake in inozyme pharma inc GuruFocus Fri, 30 May 2025 00:33:05 GMT
• millennium management llc has $5.21 million stake in inozyme pharma, inc. (nasdaq:inzy) Defense World Thu, 29 May 2025 12:31:01 GMT
• northern trust corp boosts stock holdings in inozyme pharma, inc. (nasdaq:inzy) Defense World Thu, 29 May 2025 12:18:55 GMT
• d. e. shaw & co. inc. makes new investment in inozyme pharma, inc. (nasdaq:inzy) Defense World Thu, 29 May 2025 08:39:24 GMT
• beryl capital management llc acquires significant stake in inozyme pharma inc GuruFocus Thu, 29 May 2025 07:00:00 GMT
• BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXN... TradingView Tue, 27 May 2025 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates inzy, txnm, svt, ptix on behalf of shareholders TradingView Tue, 27 May 2025 07:00:00 GMT
• Inozyme Pharma and Biohaven Pharmaceuticals Announce Leadership Changes Amid Industry Restructuring geneonline.com Mon, 26 May 2025 07:00:00 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Sun, 25 May 2025 10:03:00 GMT
• biotech stock roundup: bmrn to acquire inzy, nvax gains on vaccine approval & more MSN Sun, 25 May 2025 02:36:56 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Sat, 24 May 2025 11:15:08 GMT
• biomarin offers to buy inozyme for $270m to boost enzyme therapy biz MSN Thu, 22 May 2025 12:48:45 GMT
• Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More Zacks Investment Research Thu, 22 May 2025 07:00:00 GMT
• kahn swick & foti, llc investigates adequacy of price and process in proposed sale of inozyme pharma, inc. - inzy FinancialContent Wed, 21 May 2025 21:56:00 GMT
• INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price a... Business Wire Wed, 21 May 2025 07:00:00 GMT
• biomarin offers to buy inozyme for $270m to boost enzyme therapy biz MSN Wed, 21 May 2025 00:28:34 GMT
• biotech alert: searches spiking for these stocks today Yahoo Finance Tue, 20 May 2025 07:00:00 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Tue, 20 May 2025 06:08:40 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Mon, 19 May 2025 23:12:44 GMT
• biomarin expands rare disease portfolio with $270m inozyme acquisition MSN Mon, 19 May 2025 23:03:55 GMT
• biomarin to buy enzyme therapy developer inozyme in $270m all-cash deal MSN Mon, 19 May 2025 22:04:54 GMT
• piper sandler downgrades inozyme pharma to neutral from overweight, lowers price target to $4 from $23 marketscreener.com Mon, 19 May 2025 11:54:10 GMT
• biomarin to acquire inozyme to enhance its therapeutics portfolio World Pharmaceutical Frontiers Mon, 19 May 2025 09:48:16 GMT
• BioMarin agrees to acquire Inozyme for $270m Pharmaceutical Technology Mon, 19 May 2025 07:00:00 GMT
• BioMarin Strengthens Rare Disease Pipeline with $270 Million Inozyme Acquisition PharmExec Mon, 19 May 2025 07:00:00 GMT
• BioMarin to acquire Inozyme to enhance its enzyme therapy portfolio World Pharmaceutical Frontiers Mon, 19 May 2025 07:00:00 GMT
• BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz Yahoo Finance Mon, 19 May 2025 07:00:00 GMT
• Inozyme Pharma finds buyer in BioMarin after strategic review The Business Journals Mon, 19 May 2025 07:00:00 GMT
• BioMarin’s Bold Move in Rare Diseases: How the Inozyme Deal Unlocks a $4B Opportunity AInvest Mon, 19 May 2025 07:00:00 GMT
• BioMarin: Inozyme Acquisition Falls Short Of Offsetting Looming Revenue Risks (Downgrade) Seeking Alpha Mon, 19 May 2025 07:00:00 GMT
• BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXN... TradingView Mon, 19 May 2025 07:00:00 GMT
• td cowen downgrades inozyme pharma to hold from buy, price target is $4 MarketScreener Mon, 19 May 2025 07:00:00 GMT
• raymond james downgrades inozyme pharma to market perform from outperform MarketScreener Mon, 19 May 2025 07:00:00 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Sun, 18 May 2025 16:47:59 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Sun, 18 May 2025 08:16:36 GMT
• StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A Genetic Engineering and Biotechnology News Sun, 18 May 2025 07:00:00 GMT
• BioMarin Expands Rare Disease Portfolio with $270M Inozyme Acquisition Insider Monkey Sun, 18 May 2025 07:00:00 GMT
• The week in pharma: action, reaction and insight – week to May 16 The Pharma Letter Sun, 18 May 2025 07:00:00 GMT
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GlobeNewswire Sun, 18 May 2025 07:00:00 GMT
• inozyme pharma (nasdaq:inzy) stock rating lowered by wedbush Defense World Sun, 18 May 2025 07:00:00 GMT
• wells fargo & company reaffirms equal weight rating for inozyme pharma (nasdaq:inzy) Defense World Sun, 18 May 2025 07:00:00 GMT
• BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover MSN Sat, 17 May 2025 22:41:30 GMT
• biomarin to buy enzyme therapy developer inozyme in $270m all-cash deal MSN Sat, 17 May 2025 22:12:29 GMT
• inozyme stock rockets 179% after biomarin agrees to acquire the company for $270m: retail sentiment brightens MSN Sat, 17 May 2025 17:09:04 GMT
• Leerink bullish on BioMarin following Inozyme deal, expects additional BD Yahoo Finance Sat, 17 May 2025 07:00:00 GMT
• biomarin stock rises following inozyme pharma acquisition Investing.com Australia Sat, 17 May 2025 07:00:00 GMT
• wedbush has negative outlook for inozyme pharma q2 earnings Defense World Sat, 17 May 2025 07:00:00 GMT
• inozyme pharma (inzy) downgraded by needham analyst | inzy stock news GuruFocus Sat, 17 May 2025 03:18:18 GMT
• jefferies downgrades inozyme pharma to neutral from buy marketscreener.com Fri, 16 May 2025 18:37:06 GMT
• BioMarin Pharmaceutical: Balancing Opportunities and Risks Amid Inozyme Acquisition and Market Challenges TipRanks Fri, 16 May 2025 18:34:03 GMT
• biomarin (bmrn) set to acquire inozyme pharma for $270m | bmrn stock news GuruFocus Fri, 16 May 2025 17:46:53 GMT
• leerink bullish on biomarin following inozyme deal, expects additional bd TipRanks Fri, 16 May 2025 17:45:14 GMT
• Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens MSN Fri, 16 May 2025 17:29:35 GMT
• inozyme downgraded to equal weight from overweight at wells fargo TipRanks Fri, 16 May 2025 15:43:48 GMT
• inozyme pharma, emerson electric, stanley black & decker TradingView Fri, 16 May 2025 15:39:04 GMT
• biomarin bolsters pipeline with $270 million inozyme pharma takeover MSN Fri, 16 May 2025 15:00:50 GMT
• biomarin says inozyme deal to strengthen enzyme therapies portfolio TipRanks Fri, 16 May 2025 13:55:56 GMT
• wedbush downgrades inozyme pharma to neutral from outperform, adjusts price target to $4 from $7 marketscreener.com Fri, 16 May 2025 13:27:06 GMT
• BioMarin to buy enzyme therapy developer Inozyme in $270M all-cash deal MSN Fri, 16 May 2025 12:19:21 GMT
• biomarin to acquire inozyme for $4.00 per share in cash, or $270m TipRanks Fri, 16 May 2025 11:49:22 GMT
• BioMarin to buy rare disease drugmaker Inozyme for $270M BioPharma Dive Fri, 16 May 2025 07:00:00 GMT
• BioMarin To Acquire Inozyme Pharma For About $270 Mln In Cash Nasdaq Fri, 16 May 2025 07:00:00 GMT
• BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease MedCity News Fri, 16 May 2025 07:00:00 GMT
• BioMarin grows enzyme portfolio with $270M Inozyme buy FirstWord Pharma Fri, 16 May 2025 07:00:00 GMT
• Shareholder Alert: The Ademi Firm investigates whether Inozyme Pharma, Inc. is obtaining a Fair Price for its Public Shareholders Business Wire Fri, 16 May 2025 07:00:00 GMT
• Dollar Stock Skyrockets 179% On BioMarin Takeover Investor's Business Daily Fri, 16 May 2025 07:00:00 GMT
• BioMarin's $270M Acquisition Brings First-Ever Treatment for Fatal Childhood Bone Disease to Phase 3 Stock Titan Fri, 16 May 2025 07:00:00 GMT
• BioMarin inks $270M Inozyme buyout, bagging phase 3 prospect in first M&A move of the Sabry era Fierce Biotech Fri, 16 May 2025 07:00:00 GMT
• BioMarin stock rises following Inozyme Pharma acquisition Investing.com Fri, 16 May 2025 07:00:00 GMT
• INZY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inozyme Pharma, Inc. Is Fair to Shareholders Business Wire Fri, 16 May 2025 07:00:00 GMT
• SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inozyme Pharma, Inc. - INZY PR Newswire Fri, 16 May 2025 07:00:00 GMT
• BioMarin Pharmaceutical Inc. agreed to acquire Inozyme Pharma, Inc. for approximately $260 million. MarketScreener Fri, 16 May 2025 07:00:00 GMT
• Inozyme stock rating cut to Hold at Jefferies, target to $4 from $15 Investing.com Fri, 16 May 2025 07:00:00 GMT
• TD Cowen cuts Inozyme stock rating post-acquisition news Investing.com Fri, 16 May 2025 07:00:00 GMT
• BioMarin’s $270m Inozyme Buy Fits Right Into Enzyme Therapy Business insights.citeline.com Fri, 16 May 2025 07:00:00 GMT
• BioMarin stock in focus on M&A deal with Inozyme (BMRN:NASDAQ) Seeking Alpha Fri, 16 May 2025 07:00:00 GMT
• Inozyme Pharma (INZY) Downgraded by Wells Fargo | INZY Stock News GuruFocus Fri, 16 May 2025 07:00:00 GMT
• Biomarin snags potential ‘first-in-disease’ ERT in $270M Inozyme buy BioWorld MedTech Fri, 16 May 2025 07:00:00 GMT
• SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Inozyme Pharma, Inc. (INZY) TradingView Fri, 16 May 2025 07:00:00 GMT
• Inozyme Pharma’s Big Leap: Why INZY Is Surging on BioMarin’s Acquisition News RagingBull Fri, 16 May 2025 07:00:00 GMT
• BioMarin to acquire Inozyme for $270 million By Investing.com Investing.com Australia Fri, 16 May 2025 07:00:00 GMT
• BioMarin makes Phase 3 buy, paying $270M for rare disease outfit Inozyme Endpoints News Fri, 16 May 2025 07:00:00 GMT
• biomarin’s bold move: a strategic play to dominate rare disease therapies with inozyme’s breakthrough inz-701 AInvest Fri, 16 May 2025 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates chtr and inzy on behalf of shareholders The Malaysian Reserve Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma’s strategic acquisition by biomarin: analyst holds rating amid favorable shareholder outcome and strategic alignmen... TipRanks Fri, 16 May 2025 07:00:00 GMT
• biomarin strengthens enzyme therapy business with acquisition of inozyme pharma Yahoo Finance Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded after biomarin acquisition announcement | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• sector update: health care stocks flat to higher premarket friday marketscreener.com Fri, 16 May 2025 07:00:00 GMT
• transcript : biomarin pharmaceutical inc., inozyme pharma, inc. - m&a call marketscreener.com Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded by wells fargo following acquisition news | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• jefferies downgrades inozyme (inzy) after acquisition announceme GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded following acquisition deal | inzy stoc GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma (inzy) downgraded by needham analyst | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma (inzy) sees price target slash and downgrade by jefferies | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• biomarin pharmaceutical (bmrn) set to acquire inozyme pharma for GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded following acquisition agreement | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• biomarin pharmaceutical to acquire inozyme pharma for $270 million marketscreener.com Fri, 16 May 2025 07:00:00 GMT
• inozyme (inzy) downgraded following acquisition by biomarin | inzy stock news GuruFocus Fri, 16 May 2025 07:00:00 GMT
• biomarin (bmrn) expands enzyme therapy portfolio with inozyme ac GuruFocus Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) shares purchased by dimensional fund advisors lp Defense World Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma’s inz-701 shows promising results in energy-3 study, highlighting investment potential TipRanks Fri, 16 May 2025 07:00:00 GMT
• inozyme pharma, inc. (nasdaq:inzy) given consensus recommendation of “buy” by brokerages Defense World Thu, 15 May 2025 08:49:33 GMT
• inozyme (inzy) advances energy 3 trial for enpp1 deficiency trea GuruFocus Thu, 15 May 2025 01:43:29 GMT
• Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights GlobeNewswire Wed, 14 May 2025 07:00:00 GMT
• INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients Contemporary Pediatrics Wed, 14 May 2025 07:00:00 GMT
Inozyme Pharma, Inc(NASDAQ:INZY) 
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare gen...
Website: http://www.inozyme.com
Founded: 2015
CEO: Axel Bolte
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends